CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.255
https://www.valueinhealthjournal.com/article/S1098-3015(24)00370-X/fulltext
Section Title :
Section Order :
11608
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00370-X&doi=10.1016/j.jval.2024.03.255